Future relevance of CSF biomarkers in modern MS treatment

Georg Pilz* (First author), Peter Wipfler (First author), Andrea Harrer (Co-author), Barbara Holl (Co-author), Katrin Oppermann (Co-author), Stefan Golaszewski (Co-author), Eugen Trinka (Co-author), Jörg Kraus (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

Original languageGerman
Pages (from-to)383-388
JournalLaboratoriumsMedizin-Journal of Laboratory Medicine
Volume36
Issue number6
DOIs
Publication statusPublished - 2012

Keywords

  • RELAPSING MULTIPLE-SCLEROSIS
  • PLACEBO-CONTROLLED TRIAL
  • CEREBROSPINAL-FLUID
  • OLIGOCLONAL BANDS
  • ORAL FINGOLIMOD
  • NATALIZUMAB TREATMENT
  • FTY720 FINGOLIMOD
  • IMMUNE
  • INTERFERON
  • DIAGNOSIS

Cite this